Shares of ChemoCentryx Inc. plunged 44.8% in trading on Tuesday after the Food and Drug Administration questioned the rationale behind some of the clinical data for avacopan, an experimental treatment ...
Patrick Jagoda, UChicago professor in English and cinema and media studies, Guggenheim fellow, and executive editor of Critical Inquiry, is a highly achieved academic. But his investigation as to what ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback